Marta Sokolowska, Ph.D., serves as Associate Director for Controlled Substances in the Center for Drug Evaluation and Research. She joined FDA in December 2018 and oversees the Controlled Substance Staff (CSS). CSS provides consultation throughout FDA on evaluation of abuse potential of drugs and advises on all matters related to domestic and international drug scheduling.
Dr. Sokolowska is a recognized expert in drug abuse potential assessment and scheduling strategies. She has facilitated initiatives to improve public health by advancing the science of assessing abuse liability, including organizing and participating in numerous scientific meetings with FDA, academia, and industry experts. Her past leadership roles include serving as Vice President of Medical and External Affairs at Depomed Inc. and Head of Medical Affairs and the Center for Abuse Prevention and Evaluation at Grunenthal USA.
Dr. Sokolowska earned her doctoral degree in psychology from McMaster University in Canada.